All News

Experts highlight how leveraging organizational scale, data analytics, and community partnerships can enable independent pharmacies to identify and address pharmacy deserts.

The authors note this is the first study to assess cerebrovascular endothelial extracellular vesicles within a cognitive condition.

Empathy is being left outside the exam room door.

Federal court reviews standing to challenge to federal agency action.

Approved with 3 new indications, bimekizumab-bkzx is the first and only interleukin-17 inhibitor approved for these diseases.

The researchers estimate that pregnancy losses because of malaria and parasitemia risk before conception was reduced by 65% to 86%.

The approval enables more convenient flu immunization options for patients.

The decision expands treatment options for patients with transplant-ineligible newly diagnosed multiple myeloma (NDMM).

Ponsegromab displayed significant and robust increases in body weight at the completion of the study for all doses.

Dermatomal reactions could occur following recombinant zoster vaccine to treat shingles.

The chief product and strategy officer at Linus Health is hopeful that pharmacists can be key players in the detection of mild cognitive impairment.

Three of the largest pharmacy benefit managers ––Express Scripts, Optum, and Caremark––are listed in the suit.

The rare disease can result in progressive neurological symptoms and organ complications.

The use of devices like Apple watches may offer a more affordable and less burdensome modality to diagnose atrial fibrillation.

The CRAFT (NCT04551521) trial is still ongoing to assess findings in the remaining patient arms.

Using the term "pseudodementia" contributes to the mismanagement and mistreatment of the disease.

Federal statutes and regulations outline the expectations

Improvements in survival outcomes were seen among those at high risk for DLBCL who received 6x R-CHOP21 + 2R.

Amivatamab-vmjw is a fully-human bispecific antibody targeting EGFR and MET with immune cell-directed activity.

Results displayed a non-inferior immune response of the co-administered vaccines, compared to administration in individual visits.

Luspatercept reduced the need for transfusion in patients with myelofibrosis (MF).

Jenni Zilka discusses the growing issue of "pharmacy deserts" and the need to maintain the financial viability of pharmacies.

Using ultrasound and clinicopathological characteristics, the studied nomograms effectively evaluated recurrence risk in HR-/HER2+ and HR+/HER2+ breast cancer.

Patients with for HER2-positive breast cancer have an increased risk of developing brain tumors.

Seroconversion was observed in 95.8% of participants but dropped to 75.6% at the 4-year follow-up.

Though hospitalizations and test positivity remain at modest levels, wastewater analysis indicates high circulation of SARS-CoV-2, especially in western states.

Pembrolizumab is an anti-programmed death receptor 1 (PD-1) therapy designed to increase the immune system’s ability to detect and fight tumor cells.

These pharmacies address cost, understanding, and safety concerns through high-touch support and coordination.